Business
Adia Nutrition Officially Enters $15.1 Billion Global Stem Cell Market with Domestic Treatments by Successful Opening of First Florida Location
Adia Nutrition Officially Enters $15.1 Billion Global Stem Cell Market with Domestic Treatments by Successful Opening of First Florida Location.
About this update from Adia Nutrition, Inc.
[{"type":"text","content":"\n WINTER PARK, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. (OTC Pink: ADIA), through its medical division Adia Med, is strategically positioning itself to capture a significant share of the growing $15.1 billion global stem cell market. Adia Med’s clinic in Winter Park, Florida, now offers stem cell treatments utilizing 361 human cell, tissue, and cellular and tissue-based products (HCT/Ps), aiming to provide an experience comparable to some of the world’s most recognized locations like Panama, Mexico, Brazil and Switzerland with the advantage of using FDA compliant, high-quality umbilical cord stem cells and the convenience of a U.S. location. \"With the global stem cell market expanding, we see an opportunity to make these treatments more accessible in the U.S.,\" said Larry Powalisz, CEO of Adia Nutrition. \"Adia Med focuses on delivering care with advanced, ethically sourced umbilical cord stem cells.\" Adia Med's treatment protocols are designed to align with practices from international clinics but emphasize: Quality Stem Cells: Utilizing umbilical cord stem cells noted for their potential in various medical applications.Convenience: Eliminating the need for patients to travel internationally for treatment, thus reducing associated uncertainties, logistics, and costs.Compliance and Safety: Operating under U.S. FDA health regulations, with a focus on safety, transparency, and ethical practices. Adia Med 361 HCT/Ps are vetted for FDA compliance ensuring safety and efficacy. \"Many patients have traveled abroad for treatments which we now offer locally in Florida,\" added Dr. Sher, Chief Stem Cell Medical Officer at Adia Med. \"Our approach aims to offer treatments in a familiar, regulated setting with convenient follow-up care.\" Adia Med's clinic has started treating patients for a range of conditions, including inflammation, autoimmune conditions and various orthopedic issues, exploring the potential of stem cell therapy in regenerative medicine. * As Adia Nutrition enters this market, the company aims to enhance access to these treatments and contribute to the broader understanding and application of stem cell and other HCT/P therapies. Mr. Powalisz further stated, \"Shareholders and investors, feel free to reach out to me to arrange a visit to our new clinic.\" Disclaimer:*Same Surgical Proce...